Ngā hua rapu - Benjamin Scheier
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
Metastatic Merkel cell carcinoma response to nivolumab mā Frances M. Walocko, Benjamin Scheier, Paul W. Harms, Leslie A. Fecher, Christopher D. Lao
I whakaputaina 2016Artigo -
2
Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Pati... mā Gregory N. Gan, Andrew Weickhardt, Benjamin Scheier, Robert C. Doebele, Laurie E. Gaspar, Brian D. Kavanagh, D. Ross Camidge
I whakaputaina 2014Artigo -
3
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer mā Andrew Weickhardt, Benjamin Scheier, Joseph Burke, Gregory N. Gan, Xian Lu, Paul A. Bunn, Dara L. Aisner, Laurie E. Gaspar, Brian D. Kavanagh, Robert C. Doebele, D. Ross Camidge
I whakaputaina 2012Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Oncology
Cancer
Cancer research
Crizotinib
Lung cancer
Malignant pleural effusion
Anaplastic lymphoma kinase
Antibody
Avelumab
Carcinoma
Chemotherapy
Epidermal growth factor receptor
Erlotinib
Erlotinib Hydrochloride
Gefitinib
Immunology
Immunotherapy
Lesion
Malignancy
Merkel cell carcinoma
Monoclonal antibody
Nivolumab
Progression-free survival
Radiation therapy
Receptor
Surgery
Tumor progression
Tyrosine kinase